진단기준의 변화 ; 주의력결핍 과잉행동장애(attention-deficit hyperactivity disorder, ADHD)는 과잉행동과 부주의, 충동성의 세 가지 특성을 가지는 장애이다. 2013년에 개정된 DSM-5에서는 이전 진단기준에 비하여 발달학적 관점을 더 고려하였다. DSM-5에서는 ADHD의 발병연령을 7세 이전에서 12세 이전으로 변경하였고, 연령이 높아지면서 과잉행동이 감소하는 것을 고려하여 17세 이상, 성인에서는 부주의와 과잉행동 및 충동성 두 ...
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines 의 이용 수, 등재여부, 발행기관, 저자, 초록, 목차, 참고문헌 등 논문에 관한 다양한 정보 및 관련논문 목록과 논문의 분야별 BEST, NEW 논문 목록을 확...
Your symptoms aren’t a good way to tell if your multiple sclerosis (MS) treatment is working. Find out what your doctor looks for.
NSW Clinical Guidelines: Treatment of Opioid Dependence – 2018 ii NSW Health NSW Clinical Guidelines: Treatment of Opioid Dependence NSW Ministry of Health 73 Miller Street NORTH SYDNEY...
Because of the major difficulties in measuring clinical end points in multiple sclerosis (MS) treatment trials, there has been much enthusiasm for using magnetic resonance imaging (MRI) findings as...
institutional guidelines regarding planning parameters for... assessed treatment planning parameters. Treatment planning... 100 ms was greater than 30%. LOT and gantry period (GP) were...
https://doi.org/10.24304/kjcp.2023.33.3.153 Comparative Review of Pharmacological Treatment Guidelines for Bipolar Disorder Korean J Clin Pharm 2023;33(3):153-167 Published online September 30, 2023 © 2023 Korean...
MSIF’s international working group on access comes together to find ways of improving access to MS treatments and care around the world.
The new treatment paradigm for MS Nov 18, 2013 • 26 likes • 6,653 views MS Trust Follow... local guidelines, we had to recommend a switch to glatiramer acetate. Slide 9: MRI lesion load...
Multiple sclerosis (MS) is a progressive disease that can reduce life expectancy, but new treatments, rehabilitation, and lifestyle changes can help